Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)

Main Category: Allergy
Article Date: 08 Jun 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Cobalis Corporation (OTC:CLSC) was recently awarded two additional International Patents in Canada and Mexico and has a patent pending application in Japan. PreHistin® is patented, safe for long-term daily use and available without a prescription. It is available in a cherry flavored, all natural, proprietary cyanocobalamin (vitamin B12) sub-lingual lozenge that is taken twice daily to regulate allergy sufferers' response to both indoor and outdoor allergens with daily and year round usage.

Cobalis representatives indicate, "Cyanocobalamin has an excellent safety record, has been safety accepted by the US FDA, and has no upper dosage limits or contra-drug indications. For over 50 years the FDA has approved cyanocobalamin as a drug for anemia. Each PreHistin® lozenge contains 3.3mg Cyanocobalamin. For less than $1.00 per day, twice daily use of PreHistin® has been clinically shown to significantly increase serum vitamin B12 levels, making PreHistin® a cost effective and convenient alternative to other Vitamin B12 therapies, including needle injections."

Cobalis Board Member, Dr. Kevin Prendiville states, "These new patents, in addition to the European Union, Australian and two U.S. patents further strengthen the value and assets of Cobalis Corporation intellectual properties. Furthermore, PreHistin®'s box, labeling and related box insert have been approved by DSHEA (Dietary Supplement Health and Education Act) regulation attorneys."

About Cobalis Corp-Prehistin® "The World's First Pre-Histamine"

Headquartered in Irvine, California, Cobalis Corp. is an over the counter pharmaceutical and nutraceutical company. Its flagship product, PreHistin® is designed to prevent the primary causes of airborne allergies. PreHistin®, "The World's First Pre-Histamine" is the only Phase III clinically tested sublingual product fully patented for long term and daily use without a prescription to help relieve allergy sufferers of both indoor and outdoor allergens.

PreHistin® is manufactured by Monarch Nutraceutical Inc., a division of Nutraceutical Corporation in Ogden Utah. Nutraceutical Corp. (NUTR) was the original manufacturer of PreHistin® under the name Alleratin, which was distributed to thousands of allergy suffers without cost for compassionate use. Additional PreHistin® manufacturing partners include Marrs Printing, Walnut, CA and Merical Inc, Anaheim, CA. Domestic and international PreHistin® orders are currently fulfilled by International Sales and Marketing (ISM), Newark, NJ.

For product information and ordering please visit at http://www.PreHistin.comor call toll free 1-877-4POLLEN. For additional company information please visit their website at http://www.Cobalis.com

Source
Cobalis Corporation

Article adapted by Medical News Today from original press release.
Visit our allergy section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cobalis Corporation. "Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)." Medical News Today. MediLexicon, Intl., 8 Jun. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/152936.php>

APA
Cobalis Corporation. (2009, June 8). "Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/152936.php.

Please note: If no author information is provided, the source is cited instead.


Allergy

Most Popular Articles



Follow Our Allergy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Allergy Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »